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Abstract 
In recent years, processing of the imaging signal derived from CT, MR or positron emission has proven to be able to predict 
outcome parameters in cancer patients. The processing techniques of the signal constitute the discipline of radiomics.
The quantitative analysis of medical images outperform the information that can be obtained through traditional visual analysis.
The recognition of neoplasm molecular and genetic characteristics in a non-invasive way, based on routine radiological 
examinations, potentially allow complete tumor profiling and subsequent treatment customization at practically zero costs.
This process is further boosted with the availability of increased computing power and development of artificial intelligence 
approaches.
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Introduction
The initial diagnosis of tumour disease and its molecular 
profiling are almost always performed invasively by biopsy.
Afterwards, in the great majority of patients who are 
subsequently subjected to anticancer therapies, non-invasive 
radiological diagnostics play a fundamental role in staging and 
monitoring the evolution of the disease and the possible response 
to treatment, while further biopsies are much less frequent. 
In fact, it is universally accepted that radiological evaluable 
characteristics of the tumour, such as its size, shape, location and 
metabolism, are associated with prognosis and determine the 
therapeutic approach [1]. On the other hand, routinely performed 
CT, MR, PET and SPECT examinations consist of digitized images, 
which are highly amenable to subsequent analysis based on 
mathematical algorithms. 
It has been proven that features not perceptible to the eye of 
the reporting physician — such as intra-tumour heterogeneity, 
distribution of signal values within the tumour area and more — can 
be indicative of certain biological characteristics of the tissue, such 
as proliferation, hypoxia, necrosis, angiogenesis and even tumoural 
genotype [2, 3].
For this reason, there is an increasing interest in generating 
algorithms with artificial intelligence methods to analyse a large 
amount of radiological data. The identification of a sub-group 
of simultaneously present characteristics can allow for image 
classification and, consequently, provide answers to specific clinical 
questions. The field of diagnostic imaging that investigates the 
creation and application of these algorithms is defined as radiomics, 
and the group of features that successfully classify the radiological 
data are defined as the radiomic signature [4, 5]. 
How to define a radiomic diagnostic 
algorithm
The definition of an appropriate clinical question is of prime 
importance [6]. This choice depends on the clinical relevance and 
the available data. The prognosis and the probability of metastasis, 
necrosis, hypoxia and resistance to therapy can be evaluated. It 
is also possible to investigate in a more specific way the definition 
of variables such as the presence or absence of a specific mutation 
or the expression of certain receptors.
The typical workflow for the definition of a radiomic signature 
consists of several steps [7]: i. identification of the series of 
patients to be studied, ii. image acquisition, iii. definition of lesion 
contours (segmentation), iv. features extraction and v. model 
building and clinical validation
Each of these stages presents specific problems in the field 
of nuclear medicine.
The group of patients must be sufficiently large. To obtain 
a sufficient number, a certain amount of heterogeneity in the 
group is acceptable, but it is necessary to remember that the 
increased inhomogeneity corresponds to an increase in the 
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number of variables, which can reflect negatively on the strength 
of the results. Considering that the possible number of features of 
diagnostic images in nuclear medicine is many hundreds, multi-
institutional studies are required — with all the problems of image 
standardization that this entails.
Image acquisition must be done in a standardized and 
reproducible way. This is one of the most difficult aspects of the 
nuclear medicine context, where the acquisition parameters are 
highly variable and, in fact, they are left to the choice of each 
operator within the limits defined in the recommendations of 
national and international scientific societies. Initiatives aimed 
at standardizing image acquisition, such as the EARL project of 
the European Association of Nuclear Medicine, should be taken 
seriously into consideration [8]. 
Austrian authors have shown, through the acquisition 
of a NEMA phantom in 13 different sites following the local 
acquisition protocols, that almost all features are very sensitive to 
the conditions of image acquisition. The use of the point-spread 
function, the reduced values of the voxel size and a narrow 
Gaussian post-filtering have proved useful in minimizing feature 
variations [9]. The size of PET voxels is higher than in MRI and CT 
images. A greater volume is therefore necessary to assess tumour 
heterogeneity. For example, Brooks et al. demonstrated that in PET 
images of cervical tumours with volumes less than 45 cm3, the 
radiomic methods have a greater chance of bias [10].
The segmentation of the tumour has not yet been uniquely 
defined. For example, for PET, different segmentation methods are 
possible, based on the value of the SUV, on the percentage 
of accumulation of the tracer compared with the point of 
greatest signal intensity, on the ratio to the signal of an organ 
considered as standard or, finally, with mathematical processing 
methods (adaptive segmentation) [11, 12]. None of these 
methods has been validated clinically. Recently, an approach 
has been proposed for evaluating data on physiologically distinct 
regions of the tumour (for example by distinguishing the area with 
cellularity from the oedema and the necrotic part), with extraction 
of radiomic data from each of these regions [2].
Data extraction must include the definition of large 
series of values. Features are divided into semantic and 
non-semantic: the first type concerns data such as diameter, 
volume and shape of the tumour, whereas the second one 
concerns data extracted from the mathematical elaboration of 
the image. Features can also be distinguished according to their 
definition mode. First-order variables concern the signal values of 
the tumour voxels independently of their spatial distribution, while 
second-order data concern the analysis of the spatial distribution 
of the signal: the so-called texture analysis. Texture is defined 
as “a regular repetition of an element or pattern on a surface with 
the characteristics of brightness, colour, size and shape”. There are 
also features concerning the spatial characteristics of the tumour: 
shape-based features. Finally, different data sets can be calculated 
by analysing the tumour with the use of fractals: fractal-based 
features. The data must be subsequently selected to identify the 
non-redundant, stable and relevant ones, which have the greatest 
possibility of defining models with good diagnostic performance 
[13]. In particular, stability can be calculated by evaluating the 
consistency of the data in tests repeated at different times or with 
different methods of tumour segmentation. 
Once the most suitable data have been identified, it is necessary 
to define an algorithm for their processing in order to obtain 
a response to a given clinical question. The population is divided 
into two subsets, the first to develop the model (training group) and 
the second to validate it (testing group). Depending on whether the 
answer is a discrete or continuous variable, different mathematical 
methods can be used.
Possible clinical applications and future 
scenarios
An increasing number of authors are exploring the possible 
clinical applications of radiomics. The segmentation of head 
and neck tumours based on textural features can be applied to 
radiotherapy planning and tumour distinction from surrounding 
healthy tissues, with a possible increase in accuracy [14, 15].
Images of pulmonary solitary nodules from an 18F-FDG 
PET investigation can be studied with fractal-based algorithms, 
which have shown good accuracy in distinguishing between 
malignant lesions and non-aggressive nodules. Furthermore, 
unlike analysis based on the maximum SUV values, this approach 
does not seem to be affected by the size of the nodule [16].
The application of radiomics to FDG PET investigations in 
patients with lung and oesophageal tumours and sarcomas has been 
shown to have a high prognostic value [17–20].
The clinical validation of radiomic signatures for PET is probably 
only a matter of time. The process of standardizing the methods of 
acquisition and reconstruction of PET images currently appears to 
be the major obstacle. However, the potential clinical advantages are 
obvious, and a work of education of the medical-nuclear community 
could be the first step to be taken in this direction.
One step further: deep learning 
Recent studies in the field of artificial intelligence have also 
developed new, fundamentally different methods of image 
analysis. The so-called deep learning algorithms provide 
a “non-deterministic” analysis, where the features are not defined 
a priori but the algorithm itself defines features, selects them and 
reaches the final classification (diagnosis). All these operations with 
deep learning algorithms are conducted simultaneously during the 
training phase. The quantitative features derived from this analysis, 
on the other hand, are intrinsically difficult to describe and are not 
intuitively linked to tumour biology.
It is necessary to underline, however, that the theoretical 
bases of the deep learning process are not intuitive. In fact, the 
fundamental paradigm of scientific research, whose paternity 
is traditionally attributed to European astronomers of the fourteenth 
and fifteenth centuries (Copernicus, Galileo), consists of so-called 
hypothesis-driven research.
As we have all studied in high school, this foresees firstly the 
observation of data, preferentially by means of quantification tools, 
followed by a hypothesis formulation about the laws regulating 
the system in which the phenomenon occurs. Finally, the 
hypothesis must be confirmed by reproducible experiments. In 
medical sciences, typical hypothesis-driven research involves the 
evaluation of a given variable (i.e. a drug) by analysing its effect 
on a population compared with a control group.
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The mass of radiomic data currently exceeds the possibility 
of testing all the possible features with this type of approach. 
An alternative strategy is coming into play: the so called “data-
driven hypothesis”. In this scenario, the undifferentiated collection 
of enormous amounts of data (data mining) is followed by the 
generation of signatures capable of separating two or more 
groups, but without specifying in advance what the determining 
elements are and without using specifically selected data [21, 22].
Actually, deep learning applications are used in automatic 
speech and image recognition, drug discovery, commercial 
advertising, financial fraud detection and for military purposes. 
A deep learning model is conceptually extremely different 
from the traditional method of subjective image interpretation, 
since an artificial neural network autonomously defines and 
extracts features in order to classify the input data. This unavoidably 
will increase doctors’ reluctance to accept in clinical practice the 
therapeutic decision-making paradigms based only on opaque 
quantitative characteristics. On the other hand, the recent 
catastrophic effects related to the hasty application of artificial 
intelligence in the field of civil aviation [23] provide a more than 
reasonable justification for the distrust of clinical radiologists.
Hopefully, radiomic models should try to be readable in 
correlation with more established radiology models [24]. At 
this stage, a combination of traditional radiological interpretation 
models with radiomic functionalities could increase diagnostic 
accuracy in oncology and would seem to be a reasonable 
compromise.
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